The functional and structural characterization of a novel oncogene GIG47 involved in the breast tumorigenesis

BMC Cancer

Volumn 12, Issue , 2012, Pages

  Han, Kyou Hoon ^a   Lee, Si Hyung ^a   Ha, Seon Ah ^b   Kim, Hyun K ^b   Lee, CheWook ^a   Kim, Do Hyoung ^a   Gong, Kee H ^b   Yoo, JinAh ^b   Kim, Sanghee ^b   Kim, Jin W ^b  

^a Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^b The Catholic University of Korea   (South Korea)

Author keywords

Anti cancer agents; Breast cancer; Gig47; Oncogene; Three dimensional structure

Indexed keywords

HEME; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; STEROID;

ALPHA HELIX; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER INVASION; CARCINOGENICITY; CELL STRAIN MCF 7; COLON CARCINOMA; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVATION; GENE EXPRESSION PROFILING; GENE FUNCTION; GENE OVEREXPRESSION; GENE STRUCTURE; GENE TARGETING; GENETIC TRANSFECTION; HETERONUCLEAR NUCLEAR MAGNETIC RESONANCE; HUMAN; HUMAN CELL; HUMAN TISSUE; LEUKEMIA; LUNG CARCINOMA; LYMPHOMA; MOLECULAR GENETICS; MOLECULAR MODEL; MOUSE; NONHUMAN; ONCOGENE; ONCOGENE GIG47; PRIMARY TUMOR; PROTEIN BINDING; SEQUENCE HOMOLOGY; SKIN CARCINOMA; STRUCTURE ANALYSIS; UTERINE CERVIX CARCINOMA;

BREAST NEOPLASMS; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; CLONING, MOLECULAR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MITOGEN-ACTIVATED PROTEIN KINASES; MODELS, MOLECULAR; NERVE TISSUE PROTEINS; PHOSPHATIDYLINOSITOL 3-KINASES; PROTEIN STRUCTURE, SECONDARY; RNA INTERFERENCE; SIGNAL TRANSDUCTION;

EID: 84863100062     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-12-274     Document Type: Article

References (28)

1. Gonzalez-Angulo AM, Morales-Vasquez F, Hortobagyi GN. Overview of resistance to systemic therapy in patients with breast cancer. Adv Exp Med Biol 2007, 608:1-22. 10.1007/978-0-387-74039-3_1, 17993229.
2. Foekens JA, Peters HA, Portengen H, Noordergraaf E, Berns EMJ, Klijin JGM. Cell biological prognosis factors in breast cancer: a review. J Clin Immunoass 1991, 14:184-195.
3. Weinberg RA. Oncogenes and tumor suppressor genes. CA Cancer J Clin 1994, 44:160-170. 10.3322/canjclin.44.3.160, 7621068.
4. Bishop JM. Molecular themes in oncogenesis. Cell 1991, 64:235-248. 10.1016/0092-8674(91)90636-D, 1988146.
5. Cooper GM. Oncogenes 1995, Jones and Bartlett Publishers, Boston.
6. Kimura I, Yoshioka M, Konishi M, Miyake A, Itoh N. Neudesin, a novel secreted protein with a unique primary structure and neurotrophic activity. J Neurosci Res 2005, 79(3):287-294. 10.1002/jnr.20356, 15605373.
7. Kimura I, Nakayama Y, Yamauchi H, Konishi M, Miyake A, Mori M, Ohta M, Itoh N, Fujimoto M. Neurotrophic activity of neudesin, a novel extracellular heme-binding protein, is dependent on the binding of heme to its cytochrome b5-like heme/steroid-binding domain. J Biol Chem 2008, 283(7):4323-4331.
8. Kimura I, Konishi M, Asaki T, Furukawa N, Ukai K, Mori M, Hirasawa A, Tsujimoto G, Ohta M, Itoh N, Fujimoto M. Neudesin, an extracellular heme-binding protein, suppresses adipogenesis in 3 T3-L1 cells via the MAPK cascade. Biochem Biophys Res Commun 2009, 381(1):75-80. 10.1016/j.bbrc.2009.02.011, 19351598.
9. Kimura I, Konishi M, Miyake A, Fujimoto M, Itoh N. Neudesin, a secreted factor, promotes neural cell proliferation and neuronal differentiation in mouse neural precursor cells. J Neurosci Res 2006, 83(8):1415-1424. 10.1002/jnr.20849, 16547973.
10. Ma L, Broomfield S, Lavery C, Lin SL, Xiao W, Bacchetti S. Up-regulation of CIR1/CROC1 expression upon cell immortalization and in tumor-derived human cell lines. Oncogene 1998, 17(10):1321-1326. 10.1038/sj.onc.1202058, 9771976.
11. Neubauer H, Clare SE, Kurek R, Fehm T, Wallwiener D, Sotlar K, Nordheim A, Wozny W, Schwall GP, Poznanović S. Breast cancer proteomics by laser capture microdissection, sample pooling, 54-cm IPG IEF, and differential iodine radioisotope detection. Electrophoresis 2006, 27(9):1840-1852. 10.1002/elps.200500739, 16645950.
12. Lee H, Mok KH, Muhandiram R, Park KH, Suk JE, Kim DH, Chang J, Sung YC, Choi KY, Han KH. Local structural elements in the mostly unstructured transcriptional activation domain of human p53. J Biol Chem 2000, 275:29426-29432. 10.1074/jbc.M003107200, 10884388.
13. Chi SW, Lee SH, Kim DH, Ahn MJ, Kim JS, Woo JY, Torizawa T, Kainosho M, Han KH. Structural details on mdm2-p53 interaction. J Biol Chem 2005, 280:38795-38802. 10.1074/jbc.M508578200, 16159876.
14. Chi SW, Kim DH, Lee SH, Chang I, Han KH. Pre-structured motifs in the natively unstructured preS1 surface antigen of hepatitis B virus. Protein Sci 2007, 16:2108-2117. 10.1110/ps.072983507, 2204132, 17766372.
15. Liang P, Pardee AB. Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science 1992, 257(5072):967-971. 10.1126/science.1354393, 1354393.
16. Liang P, Pardee AB. Analysing differential gene expression in cancer. Nat Rev Cancer 2003, 3(11):869-876. 10.1038/nrc1214, 14668817.
17. Wishart DS, Sykes BD. Chemical shifts as a tool for structure determination. Methods Enzymol 1994, 239:363-392.
18. Wishart DS, Bigam CG, Yao J, Abildgaard F, Dyson HJ, Oldfield E, Markley JL, Sykes BD. 1H, 13C and 15N chemical shift referencing in biomolecular NMR. J Biomol NMR 1995, 6:135-140.
19. Schwarzinger S, Kroon GJ, Foss TR, Chung J, Wright PE, Dyson HJ. Sequence-dependent correction of random coil NMR chemical shifts. J Am Chem Soc 2001, 123:2970-2978. 10.1021/ja003760i, 11457007.
20. Eswar N, Eramian D, Webb B, Shen MY, Sali A. Protein structure modeling with MODELLER. Methods Mol Biol 2008, 426:145-159. 10.1007/978-1-60327-058-8_8, 18542861.
21. Song J, Vinarov D, Tyler EM, Shahan MN, Tyler RC, Markley JL. Hypothetical protein At2g24940.1 from Arabidopsis thaliana has a cytochrome b5 like fold. J Biomol NMR 2004, 30:215-218.
22. Linding R, Russell RB, Neduva V, Gibson TJ. GlobPlot: Exploring protein sequences for globularity and disorder. Nucleic Acids Res 2003, 31:3701-3708. 10.1093/nar/gkg519, 169197, 12824398.
23. Kussie PH, Gorina S, Marechal V, Elenbaas B, Moreau J, Levine AJ, Pavletich NP. Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain. Science 1996, 274:948-953. 10.1126/science.274.5289.948, 8875929.
24. Schon O, Friedler A, Bycroft M, Freund SM, Fersht AR. Molecular mechanism of the interaction between MDM2 and p53. J Mol Biol 2002, 323:491-501. 10.1016/S0022-2836(02)00852-5, 12381304.
25. Vassilev LT, Vu BT, Graves B, Carvajal D, Podlaski F, Filipovic Z, Kong N, Kammlott U, Lukacs C, Klein C. In vivo activation of the p53 pathway by small-molecule antagonists of MDM2. Science 2004, 303:844-848. 10.1126/science.1092472, 14704432.
26. García-Echeverría C, Chène P, Blommers MJ, Furet P. Discovery of potent antagonists of the interaction between human double minute 2 and tumor suppressor p53. J Med Chem 2000, 43:3205-3208. 10.1021/jm990966p, 10966738.
27. Liu R, Hu J. HemeBIND: a novel method for heme binding residue rediction by combining structural and sequence information. BMC Bioinfirmatics 2011, 12:207.
28. Min L, Strushkevich NV, Harnastai IN, Iwamoto H, Gilep AA, Takemori H, Usanov SA, Nonaka Y, Hori H, Gavin P. Molecular identification of adrenal inner zone antigen as a heme-binding protein. FEBS J 2005, 272:5832-5843. 10.1111/j.1742-4658.2005.04977.x, 16279947.